Low Doses Amitriptyline & Chronic Neck Pain

NCT ID: NCT01561209

Last Updated: 2017-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

212 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-03-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this prospective randomized and controlled study is to evaluate the efficacy and safety of low dose of amitriptyline (5 mg) in the management of chronic neck pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with chronic neck pain, lasting since at least 3 months, are recruited from our pain clinic. After verification of inclusion and exclusion criteria, patients consenting to enter the study are assigned randomly to one of the following groups: 1-Amitriptyline 5 mg for 2 months 2- placebo for 2 months. Co-morbidities and other painful conditions are noted, and then clinical evaluation of the patient is performed; pain is assessed according to Visual Analog Scale, anxiety, depression, insomnia and disability are evaluated by adapted scores (Bergen insomnia scale, neck pain disability score, neck pain diary \& anxiety and depression score). Patients are followed at 2 months and outcome measures are assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neck Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Amitryptiline

Amitryptiline 5 mg before bedtime

Group Type ACTIVE_COMPARATOR

Amitryptiline

Intervention Type DRUG

Amitryptiline 5 mg before bedtime for 2 months

Placebo

Placebo pill

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Placebo pill

1 before bedtime

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Amitryptiline

Amitryptiline 5 mg before bedtime for 2 months

Intervention Type DRUG

Placebo

Placebo pill

1 before bedtime

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Tryptizol Laroxyl No brand name

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronic neck pain (since more than 3 months, and more than 15 days/month)
* Normal neurologic exam
* X-ray = normal or loss of lordosis

Exclusion Criteria

* Neurologic signs or symptoms
* Past history of neck surgery
* MRI = abnormal findings except for loss of lordosis
* Past cervical trauma
* severe depression
* drug abuse
* pregnancy
* Follow-up not possible
* cardiac rhythms problems
* Glaucoma
* Urinary tract obstruction or prostatism
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St Joseph University, Beirut, Lebanon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Joseph Maarrawi

Assistant Professor : Researcher - Pain Specialist - Neurosurgeon

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joseph Maarrawi, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

St Joseph University, Beirut, Lebanon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hotel Dieu de france Hospital

Beirut, , Lebanon

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lebanon

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AMIT-CNP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Chronic Pain After Amputation
NCT00006427 COMPLETED PHASE4
Chronic Pain in Spinal Cord Injury
NCT00006428 COMPLETED PHASE4
The Role of TRP Channels in CIPN
NCT04415892 RECRUITING NA